Literature DB >> 19644903

Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.

Kiem Oen1, Lori Tucker, Adam M Huber, Paivi Miettunen, Rosie Scuccimarri, Sarah Campillo, David A Cabral, Brian M Feldman, Shirley Tse, Gaëlle Chédeville, Lynn Spiegel, Rayfel Schneider, Bianca Lang, Janet Ellsworth, Suzanne Ramsey, Paul Dancey, Earl Silverman, Anne-Laure Chetaille, Bonnie Cameron, Nicole Johnson, Jean Dorval, Ross E Petty, Karen Watanabe Duffy, Gilles Boire, Elie Haddad, Kristin Houghton, Claire Saint-Cyr, Stuart E Turvey, Susanne Benseler, Mary Cheang, Rae S M Yeung, Ciarán M Duffy.   

Abstract

OBJECTIVE: To determine early predictors of 6-month outcomes in a prospective cohort of patients with juvenile idiopathic arthritis (JIA).
METHODS: Patients selected were those enrolled in an inception cohort study of JIA, the Research in Arthritis in Canadian Children Emphasizing Outcomes Study, within 6 months after diagnosis. The juvenile rheumatoid arthritis core criteria set and quality of life measures were collected at enrollment and 6 months later. Outcomes evaluated included inactive disease, Juvenile Arthritis Quality of Life Questionnaire (JAQQ) scores, and Childhood Health Assessment Questionnaire (C-HAQ) scores at 6 months.
RESULTS: Thirty-three percent of patients had inactive disease at 6 months. Onset subtype and most baseline core criteria set measures correlated with all 3 outcomes. Relative to oligoarticular JIA, the risks of inactive disease were lower for enthesitis-related arthritis, polyarthritis rheumatoid factor (RF)-negative JIA, and polyarthritis RF-positive JIA, and were similar for psoriatic arthritis. In multiple regression analyses, the baseline JAQQ score was an independent predictor of all 3 outcomes. Other independent baseline predictors included polyarthritis RF-negative and systemic JIA for inactive disease; C-HAQ score and polyarthritis RF-positive JIA for the 6-month C-HAQ score; and active joint count, pain, and time to diagnosis for the 6-month JAQQ score.
CONCLUSION: Clinical measures soon after diagnosis predict short-term outcomes for patients with JIA. The JAQQ is a predictor of multiple outcomes. Time to diagnosis affects quality of life in the short term.

Entities:  

Mesh:

Year:  2009        PMID: 19644903     DOI: 10.1002/art.24539

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  28 in total

Review 1.  Management of juvenile idiopathic arthritis: hitting the target.

Authors:  Claas Hinze; Faekah Gohar; Dirk Foell
Journal:  Nat Rev Rheumatol       Date:  2015-01-06       Impact factor: 20.543

2.  Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.

Authors:  Panayiota Nalbanti; Florentia Kanakoudi-Tsakalidou; Maria Trachana; Polyxeni Pratsidou-Gertsi; Evangelia Farmaki; Panagiotis Bamidis; Fotios Papachristou
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

3.  Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis.

Authors:  Elham Rezaei; Daniel Hogan; Brett Trost; Anthony J Kusalik; Gilles Boire; David A Cabral; Sarah Campillo; Gaëlle Chédeville; Anne-Laure Chetaille; Paul Dancey; Ciaran Duffy; Karen Watanabe Duffy; John Gordon; Jaime Guzman; Kristin Houghton; Adam M Huber; Roman Jurencak; Bianca Lang; Kimberly Morishita; Kiem G Oen; Ross E Petty; Suzanne E Ramsey; Rosie Scuccimarri; Lynn Spiegel; Elizabeth Stringer; Regina M Taylor-Gjevre; Shirley M L Tse; Lori B Tucker; Stuart E Turvey; Susan Tupper; Rae S M Yeung; Susanne Benseler; Janet Ellsworth; Chantal Guillet; Chandima Karananayake; Nazeem Muhajarine; Johannes Roth; Rayfel Schneider; Alan M Rosenberg
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580

4.  High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.

Authors:  Mikel Alberdi-Saugstrup; Marek Zak; Susan Nielsen; Troels Herlin; Ellen Nordal; Lillemor Berntson; Anders Fasth; Marite Rygg
Journal:  Rheumatol Int       Date:  2017-03-10       Impact factor: 2.631

5.  Development and retrospective validation of the juvenile spondyloarthritis disease activity index.

Authors:  Pamela F Weiss; Robert A Colbert; Rui Xiao; Chris Feudtner; Timothy Beukelman; Esi Morgan DeWitt; Ilaria Pagnini; Tracey B Wright; Carol A Wallace
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-12       Impact factor: 4.794

6.  Delays to Care in Pediatric Lupus Patients: Data From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.

Authors:  Tamar B Rubinstein; Wenzhu B Mowrey; Norman T Ilowite; Dawn M Wahezi
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-02-07       Impact factor: 4.794

Review 7.  New advances in juvenile spondyloarthritis.

Authors:  Shirley M L Tse; Ronald M Laxer
Journal:  Nat Rev Rheumatol       Date:  2012-04-10       Impact factor: 20.543

8.  The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study.

Authors:  Ummusen Kaya Akca; Ezgi Deniz Batu; Seher Sener; Zeynep Balik; Muserref Kasap Cuceoglu; Erdal Atalay; Ozge Basaran; Yelda Bilginer; Seza Ozen
Journal:  Clin Rheumatol       Date:  2022-01-29       Impact factor: 2.980

9.  [Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care].

Authors:  M Niewerth; K Minden; J Klotsche; G Horneff
Journal:  Z Rheumatol       Date:  2014-08       Impact factor: 1.372

Review 10.  Enthesitis-related arthritis.

Authors:  Amita Aggarwal; Durga Prasanna Misra
Journal:  Clin Rheumatol       Date:  2015-08-02       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.